Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline to a range of traditional and eCommerce retailers, wholesalers, and distributors. It includes pharmaceutical products for dentists and other oral health professionals. Its Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Colgate-Palmolive looks like a high-quality but already expensive defensive business, where strong operating profitability coexists with a notable balance sheet burden. P/E of 33.7 and P/S of 3.27 are significantly above the industry median, while P/B of 120.2 looks extremely high, which usually implies limited revaluation potential without an acceleration in earnings growth. P/FCF of 18.8 does not look cheap either, although it is less concerning than P/B and P/S, and it points to a fair but not outstanding free cash flow valuation. At the same time, the company’s margins are strong: gross margin of 60.4%, operating margin of 14.9%, and net margin of 9.7% are noticeably above industry benchmarks, confirming the durability of the brand’s pricing power. ROA of 12.1% and ROI of 25.0% are also solid, and EPS and forward EPS are above the median, which supports the fundamental resilience of the valuation. However, the trend in margins and returns has generally weakened over time: operating margin and net margin were higher in prior periods, and ROA and ROI have also declined from stronger levels. Revenue and gross profit continue to grow, but the pace appears moderate, with no signs of acceleration that could justify such high multiples. Debt load remains a key risk: debt/equity of 13.8 and long-term debt of $7.8 billion, combined with very low equity, create valuation vulnerability, especially against the backdrop of weak liquidity. Quick ratio of 0.29 is below normal and indicates limited short-term liquidity cushion, although a current ratio of around 1.0 already looks acceptable for a mature consumer business. Dividend yield of 0.56% is not, by itself, a strong argument for valuation upside, especially since it has declined compared with previous periods. Overall, the fundamentals support business stability, but do not justify an aggressive increase in the target price, since the premium to the industry on valuation multiples is too large. For an investor, this is more a story of quality and capital preservation than of rapid growth, so a moderate conservative downward adjustment is appropriate.

Colgate-Palmolive Company

Сильный индекс, значительно упал. Быки в растерянности.

Strong index, significantly down. The bulls are confused.

Сильный индекс, без изменений. Рынок не поддерживает быков.

Strong index, flat. The market does not support the bulls.

Сильный индекс, без изменений. Отток средств из лонгов на высоком уровне.

Strong index, flat. Outflow of funds from longs at a high level.

Strong margins and stable revenue support CL, but expensive valuation multiples, weak liquidity, and high debt limit re-rating potential.

Newell Brands Inc. NWL is showing encouraging signs of a business turnaround, with its sales recovery gaining traction across multiple brands, categories and markets. The improvement reflects the company's efforts to rebuild its commercial capabilities, strengthen consumer-led innovation and improve retail execution. Higher advertising investments, new product introductions and expanding distribution are helping Newell Brands reconnect with consumers and strengthen its competitive position. The broad-based nature of this recovery suggests that its transformation strategy is beginning to translate into tangible business improvements.
In the second quarter of 2026, NWL's net sales increased 3% to approximately $2 billion, while core sales advanced 2.3%, marking the first year-over-year growth in both metrics in more than four years. Five of its six business units, seven of its top 10 brands and five of its top 10 countries delivered sales growth. The U.S. business registered approximately 5% net sales growth, while domestic distribution points increased at a mid-single-digit rate. Learning and Development recorded nearly 5% core sales growth, while Outdoor & Recreation grew nearly 4%.
A key driver behind this recovery is Newell Brands' renewed focus on innovation and brand-building. Strong demand for Graco's rotating car seats, Sharpie's writing products and Coleman's outdoor offerings highlights improving consumer acceptance of its product portfolio. Distribution gains, enhanced merchandising and stronger retailer partnerships are further supporting sales momentum. Meanwhile, the recovery in Kitchen and Home Fragrance reflects improving execution across previously challenged categories. The company's increased marketing efforts are also helping translate product innovation into stronger consumer demand and market-share gains.
Looking ahead, NWL's ability to sustain this momentum will depend on continued innovation, distribution expansion and disciplined execution. Management expects additional product launches and improved retail activation to support growth in the second half of 2026. However, inflationary pressures, tariff-related costs and uneven consumer spending remain challenges. While the recovery in several business units is encouraging, the Commercial business and certain international markets still require improvement. Sustained consumer demand and further progress across these weaker areas will be important in determining whether Newell Brands' emerging sales recovery develops into durable, company-wide growth.
BJ, CHD & CL: Strong Sales Momentum Driven by Key Growth Catalysts
BJ's Wholesale Club Holdings, Inc. BJ continues to demonstrate strong sales momentum, supported by increasing customer traffic, robust membership growth and sustained market-share gains. The warehouse club operator is witnessing healthy demand across its grocery, perishables and sundries businesses, while general merchandise is benefiting from strength in consumer electronics, home products and seasonal categories. BJ’s competitive pricing strategy, improved merchandise assortment and investments in member value are attracting shoppers amid persistent economic uncertainty. Meanwhile, growing adoption of digitally enabled services, expanding club presence and strong fuel demand are further strengthening customer engagement. These factors are reinforcing the company's competitive position and supporting its ability to sustain sales growth.
Church & Dwight Co., Inc. CHD continues to exhibit broad-based sales strength, driven by robust consumer demand, product innovation and market-share gains across its domestic, international and specialty products businesses. Strong performances from THERABREATH, HERO, ARM & HAMMER cat litter and ZICAM are supporting domestic growth, while international markets are benefiting from increasing brand penetration and favorable product mix. The company is also capitalizing on the growing popularity of premium personal care products, supported by its expanding innovation pipeline and recent acquisition of MISS MOUTH'S. Strong e-commerce momentum, distribution gains and higher marketing investments are further strengthening brand visibility and consumer engagement. These initiatives are helping Church & Dwight maintain healthy organic sales growth despite inflationary pressures and intense competition.
Colgate-Palmolive Company CL continues to demonstrate resilient sales performance, supported by its diversified product portfolio, strong international presence and sustained investments in innovation and brand-building. Growth across emerging markets, particularly India, Brazil, Mexico and China, alongside solid contributions from Europe, is supporting its overall sales trajectory. The company's Hill's Pet Nutrition business is also benefiting from premium, science-led innovation and market-share gains despite a challenging pet care environment. Meanwhile, Colgate’s new product introductions across oral care and home care, increased advertising investments and expanding digital capabilities are strengthening consumer engagement. However, softer demand, heightened competition and retailer inventory reductions in North America remain challenges, making continued international momentum and improved domestic execution important for sustaining growth.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).

NWL Sees Broad-Based Sales Recovery: What's Behind the Shift?

Colgate-Palmolive Company CL continues to strengthen its performance through innovation, premiumization, brand investments and expansion across emerging markets. The company’s strategy focuses on introducing differentiated products, improving its oral-care portfolio and leveraging its strong global brands to drive consumer demand. Investments in premium products and innovation can support sales growth and help Colgate maintain its competitive position in the global consumer-products market.
Colgate benefits from its strong presence in oral care, with brands such as Colgate providing significant scale and consumer recognition. The company is also expanding its offerings in higher-value categories, including electric toothbrushes, specialized toothpaste and other premium oral-care products. Such initiatives can help improve its product mix and support higher revenue and margins.
Innovation remains an important part of Colgate’s strategy. The company continues to introduce products designed around changing consumer preferences, including whitening, sensitivity, gum health and other specialized oral-care needs. By focusing on differentiated products, Colgate can encourage consumers to trade up and potentially generate higher value per purchase.
Colgate is also focusing on expanding its presence in emerging markets, where rising incomes, greater awareness of oral hygiene and increasing penetration of branded products can create long-term growth opportunities. Its extensive international distribution network allows the company to benefit from these trends while maintaining a broad geographic revenue base.
While Colgate’s innovation, premiumization, brand strength and emerging-market expansion provide several avenues for growth, sustaining momentum will depend on its ability to balance pricing with volume, successfully launch differentiated products and manage costs. Continued investments in brands and innovation will support long-term growth.
Colgate’s Peers
The Procter & Gamble Company PG focuses on strengthening its brands through innovation, premiumization and targeted marketing investments. The company is emphasizing superior product performance, differentiated offerings and productivity initiatives to support organic sales while managing cost pressures. PG is also leveraging e-commerce, digital capabilities and data-driven marketing to improve consumer engagement and expand reach. International expansion and emerging-market opportunities remain important long-term growth drivers for Procter & Gamble.
The Clorox Company CLX is strengthening brands, driving innovation, improving productivity and expanding core categories. Clorox also emphasizes pricing, mix improvement and cost savings to offset inflation and protect margins. CLX’s digital and e-commerce initiatives aim to improve consumer reach and engagement, while supply-chain and operational improvements support efficiency and product availability. The company is also prioritizing portfolio optimization and disciplined investments to support sales growth and profitability.
Church & Dwight Co., Inc. CHD has been strengthening its market position through a robust brand portfolio, strategic pricing and innovation. Leveraging its strong brand equity, CHD exercises pricing power to bolster profitability and overall growth. Church & Dwight also uses strategic acquisitions to enter attractive categories and broaden its brand portfolio.
CL’s Price Performance, Valuation and Estimates
Colgate’s shares have gained 2.7% in the past six months compared with the industry’s 4.4% growth.
From a valuation standpoint, CL trades at a forward price-to-earnings ratio of 21.5X compared with the industry’s average of 18.4X.
The Zacks Consensus Estimate for CL’s 2026 and 2027 EPS indicates year-over-year growth of 4.9% and 5.2%, respectively. The company’s EPS estimate for 2026 has been stable, while that for 2027 has moved south in the past 30 days.
Colgate currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Colgate's Innovation and Premiumization Drive: Can Momentum Persist?

Key Points
Colgate-Palmolive, Procter & Gamble, and Coca-Cola have durable businesses that can pay you for a lifetime.
Each has raised its dividend for at least 63 straight years and covers the payout with cash the business generates.
As of late September, the trio yields 2.41% to 2.98% from steady sales of products people buy every day.
Colgate-Palmolive (NYSE: CL), Procter & Gamble (NYSE: PG), and Coca-Cola (NYSE: KO) are three dividend stocks I'd be happy to put $1,000 into each and then forget about. I'm confident that leaders in toothpaste, laundry detergent, and soft drinks can keep paying me dividends for decades.
Their dividend histories support a buy-and-forget approach. All three are Dividend Kings -- companies that have raised their dividends for at least 50 consecutive years. As of Sept. 25, they yield about 2.4% to 3%, reflecting the staying power of their brands and their ability to hold up through just about any economic backdrop.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Colgate-Palmolive
Colgate-Palmolive controls more than 40% of the global toothpaste market and also owns a portfolio of personal and home care brands. Selling everyday essentials is why the company has been able to raise its dividend for 63 consecutive years.
The company generates strong margins across its brands. On a trailing 12-month basis, it generated $3.9 billion in free cash flow. Its dividend payout as a percentage of free cash flow was 43%, based on its current quarterly dividend of $0.53 per share, which puts its forward yield at about 2.47% -- close to $25 in annual income on a $1,000 investment.
The business is performing well in a sub-optimal consumer spending environment. Net sales increased 4.9% year over year to $5.4 billion in the second quarter of 2026. Organic sales -- excluding currency effects, acquisitions, and divestitures -- rose 2.4%.
Over the past five years, the dividend has grown at a 3.3% annualized rate. With solid free cash flow generation, management intends to keep investing in innovation and brand support. Analysts expect Colgate's earnings to grow at an annualized rate of 5% over the coming years, which should translate into similar growth in free cash flow and dividends.
Procter & Gamble
Procter & Gamble owns some of the strongest consumer brands on the planet -- including Tide, Pampers, Gillette, Crest, and Charmin -- which sets it up for consistent sales, profits, and dividend growth. That broad lineup of daily use products has powered 70 consecutive years of dividend increases.
Like many consumer companies, P&G has faced sales pressure amid inflationary pressures. Organic sales rose just 1% year over year in fiscal 2026 (ended in June), and they were flat in the most recent quarter. Even so, the company paid out 67% of free cash flow as dividends over the past year, suggesting the payout remains safe and sustainable.
The quarterly dividend is currently $1.0885 per share, yielding 2.98% forward. This would pay close to $30 in annual income on a $1,000 investment. Over the past five years, P&G has grown its dividend at a 5% annualized rate, and analysts expect earnings to rise 5% annually over the long term.
This could be a good time to take a closer look at the stock, as management aims to reaccelerate sales and regain market share over the next 12 to 18 months. If it succeeds, that progress could be a catalyst for stronger stock performance in the years ahead.
Coca-Cola
Coca-Cola is another consumer staple built around affordable products people buy every day. Each year, it sells billions of servings across a wide lineup that includes soft drinks, water, sports drinks, juice, and coffee. Beyond its namesake soda, Coca-Cola has 32 brands that each generate $1 billion in annual sales.
Earlier this year, the company raised its dividend for the 64th consecutive year. At its current quarterly rate of $0.53 per share, the forward yield is 2.41%, supported by a free cash flow payout ratio of 77%. A $1,000 investment would earn about $24 in annual income.
Coca-Cola is executing well right now. In the second quarter, global unit case volume rose 5% year over year. Organic revenue increased 6%, and a mix of expense leverage and improved margins helped drive adjusted earnings up 11% versus the year-ago quarter.
The dividend has grown at a 4.5% annualized rate over the past five years. With the company's current momentum, analysts now expect its earnings to grow 7% per year over the long term. Consumers have been buying Coke products for over a century, and that's not likely to change. It owns dozens of brands across different categories to meet consumer needs for almost any occasion, which should continue to drive steady sales and dividend growth for a long time.
Should you buy stock in Colgate-Palmolive right now?
Before you buy stock in Colgate-Palmolive, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Colgate-Palmolive wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $373,352!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,406,241!*
Now, it’s worth noting Stock Advisor’s total average return is 933% — a market-crushing outperformance compared to 212% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of September 29, 2026.
John Ballard has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Colgate-Palmolive. The Motley Fool has a disclosure policy.

I'd Put $1,000 Into Each of These 3 Dividend Stocks and Lose the Password

The Procter & Gamble Company’s PG Baby Care business in China is showing a notable recovery, supported by premium and super-premium innovation tailored to local consumer preferences. The company has focused on delivering stronger product performance around softness, comfort, dryness and skin protection, while also improving how those benefits are communicated to consumers. These efforts have helped strengthen the Pampers proposition in a market where consumers have become more selective about value and product efficacy. The improvement is especially important because China has been a difficult market for PG in recent years, making the latest Baby Care momentum a meaningful part of the company’s broader recovery in the region.
The progress is visible in the numbers. PG said its China Baby Care business has delivered double-digit organic sales growth in each of the past six quarters and gained nearly 5 points of value share over that period. The business has also returned to the No. 1 position in China Baby Care, while Greater China organic sales increased 4% in the latest quarter. A key contributor has been innovation in premium diapers, including products using silk materials designed to improve skin comfort and protection. The company also noted that Baby Care has become one of the strongest-performing categories within its China portfolio, helping support broader share gains in the market.
Looking ahead, sustaining this momentum will depend on PG’s ability to keep raising the innovation bar while maintaining a strong value proposition for increasingly discerning Chinese consumers. The company is emphasizing noticeable product performance, premiumization and stronger execution across both physical stores and digital channels. Procter & Gamble has already highlighted that its China recovery is becoming more broad-based from a channel perspective, with improving positions in offline retail, pure-play e-commerce and social-commerce platforms. If Baby Care continues to gain users through differentiated innovation and stronger consumer engagement, the category could remain an important driver of the company’s China growth momentum in fiscal 2027.
Church & Dwight Growth vs. Colgate’s Brand Strength
Church & Dwight’s CHD volume-led growth and Colgate-Palmolive’s CL pricing, innovation and category leadership highlight resilient momentum across the consumer staples space.
Church & Dwight is seeing stronger underlying momentum following its strategic portfolio actions, with volume-led organic growth and margin expansion supporting performance. In the second quarter of 2026, organic sales advanced 5.8%, including 5.1% growth in the Domestic business and 9.1% growth internationally. Adjusted gross margin expanded 40 basis points to 45.4%, while cash from operations increased 24.3%. Reflecting stronger-than-expected trends, CHD raised its 2026 organic sales growth outlook to 4%-5% from 3%-4% and now expects adjusted gross margin expansion of 100-120 basis points. Continued brand investment, productivity and international expansion remain important drivers of its growth trajectory.
Colgate continues to benefit from broad-based organic growth, strong pricing execution and improving volume trends, supported by its focus on premium, science-led innovation and higher brand investment. In the second quarter of 2026, organic sales increased 2.4%, while organic volume rose 0.8%. Growth remained particularly strong in Latin America and Asia Pacific, while North America stayed under pressure. Gross margin expanded 140 basis points to 61.5%, aided by productivity savings and pricing, while base business EPS increased 8%. CL also maintained its global leadership in toothpaste and manual toothbrushes, with year-to-date market shares of 41.3% and 32.7%, respectively.
PG’s Price Performance, Valuation & Estimates
Procter & Gamble’s shares have lost 1.5% in the past three months compared with the industry’s 2.4% fall.
From a valuation standpoint, PG trades at a forward price-to-earnings ratio of 20.62X compared with the industry’s average of 18.34X.
The Zacks Consensus Estimate for PG’s fiscal 2026 and 2027 EPS indicates year-over-year growth of 1.5% and 6.2%, respectively. The company’s EPS estimates for fiscal 2026 and 2027 have remained stable in the past seven days.
Procter & Gamble currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).

PG's Baby Care Regains China Lead on Premium Innovation Momentum

Conagra Brands, Inc. CAG is likely to witness a top-and bottom-line decline when it reports first-quarter fiscal 2027 earnings on Sept. 30. The Zacks Consensus Estimate for revenues is pegged at $2.6 billion, indicating a decrease of 1.4% from the year-ago reported number.
The consensus mark for earnings has remained unchanged over the past 30 days at 31 cents a share, which suggests a fall of 20.5% from the figure recorded in the year-ago period. CAG has a trailing four-quarter surprise of about 5%, on average.
Conagra Brands Price, Consensus and EPS Surprise
Factors Likely to Influence CAG’s Upcoming Results
Conagra Brands’ first-quarter results are likely to be pressured by soft category trends and the lingering impact of inflation-justified pricing actions implemented during fiscal 2026. Management expects organic net sales to decline in the low-single-digit range, reflecting current category trends and the wrap of prior pricing actions. New pricing initiatives are not expected to reach the market until mid-second quarter, limiting their ability to support first-quarter sales.
Margins are also likely to have remained under pressure. Management expects heightened first-quarter inflation stemming from oil-related and logistics pressures, while the roughly $40 million fiscal 2027 tariff-related cost wrap is expected to over-index to the quarter. The planned step-up in advertising and promotional spending could have added to near-term costs. Conagra expects first-quarter adjusted operating margin in the high-single-digit range, which suggests a contraction from the year-ago period’s figure of 11.8%.
Some pressures may have been partly offset by productivity efforts and continued brand support. Conagra is targeting productivity above 4% of the cost of goods sold for fiscal 2027, while increased advertising investment is focused on growth platforms such as frozen meals and meat snacks. Recent volume-share gains in frozen meals and vegetables, along with momentum in meat snacks, may also have provided some support if sustained into the quarter.
Earnings Whispers for CAG
Our proven model doesn’t conclusively predict an earnings beat for Conagra Brands this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here.
Conagra Brands currently carries a Zacks Rank #4 (Sell) and has an Earnings ESP of +3.22%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks With the Favorable Combination
Here are some companies worth considering, as our model shows that these have the right combination of elements to beat on earnings this reporting cycle.
Colgate-Palmolive Company CL currently has an Earnings ESP of +1.94% and a Zacks Rank of 3. The Zacks Consensus Estimate for its upcoming quarter’s revenues is pegged at $5.3 billion, indicating an approximately 4% rise from the figure reported in the prior-year quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for Colgate-Palmolive’s earnings is pegged at 92 cents per share, implying 1.1% growth from the year-ago quarter. CL delivered a trailing four-quarter earnings surprise of 3.2%, on average.
Philip Morris International Inc. PM currently has an Earnings ESP of +1.95% and a Zacks Rank of 3. The consensus estimate for the quarterly revenues is pinned at $11.4 billion, which suggests 5.2% growth from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for Philip Morris’ upcoming quarter’s EPS is pegged at $2.29, which calls for a 2.2% increase from the year-ago period figure. PM delivered a trailing four-quarter earnings surprise of 6%, on average.
The Coca-Cola Company KO currently has an Earnings ESP of +0.57% and a Zacks Rank #3. The consensus estimate for quarterly revenues is pegged at $12.9 billion, which indicates an improvement of about 4% from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for Coca-Cola’s upcoming quarter’s EPS is pegged at 87 cents, which calls for 6.1% growth from the figure reported in the prior-year quarter. KO delivered a trailing four-quarter earnings surprise of 4.6%, on average.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Conagra Brands Readies for Q1 Earnings: What to Expect From CAG Stock?

Key Points
McDonald’s, Colgate, and Walmart sell products people keep buying, even when money gets expensive.
Each company has a long dividend track record backed by businesses built around recurring demand.
If rates stay higher for longer, these stocks offer a mix of income, value, and everyday consumer demand.
The Federal Reserve recently raised its benchmark interest rate by 25 basis points to a target range of 3.75% to 4.00%, marking its first rate hike in more than three years as policymakers work to combat persistent inflation. But if the Fed keeps raising interest rates, dividend investors should not need to abandon stocks.
You just need companies whose customers keep showing up, whose boards treat the dividend as a core obligation, and whose 2026 moves point to staying power rather than quick fixes. Three stocks fit that narrative and are solid buys today.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
1. McDonald's: a "Dividend King" tied to everyday eating
McDonald's (NYSE: MCD) sits near the top of my dividend reliability list. In September, the board marked the company's 50th consecutive year of dividend increases and joined the club of "Dividend Kings," a small group of U.S. companies with half a century of annual raises. The latest declaration set the quarterly dividend at $1.93 per share, up 4%, with an annualized rate of $7.72, and management framed that record as proof of a durable business model and disciplined capital allocation.
Underneath this consistent payout, the story is simple. McDonald's sells affordable food in more than one hundred countries, runs an asset‑light franchise system, and keeps reinvesting in digital ordering, drive‑throughs, and store upgrades.
On top of this, McDonald's is reworking its value strategy after U.S. sales growth slowed recently, Bloomberg reported, with plans for a longer-term approach aimed at budget-conscious customers. It is using temporary deals and app promotions, including $2 breakfast sandwiches and free fries with a $1 purchase, to boost demand. So, if rates climb or cost pressures rise, the McDonald's customer base leans on value and convenience, which helps support cash flow that can continue to cover a growing dividend.
2. Colgate-Palmolive: toothpaste and soap funding a long dividend record
Colgate-Palmolive (NYSE: CL) lives in bathrooms and kitchens -- my bathroom included -- which is exactly why it holds up in tighter conditions. In March 2026, the board raised the quarterly common stock dividend to $0.53 per share from $0.52, lifting the annual rate to $2.12. Colgate has also paid uninterrupted dividends on its common stock since 1895.
The underlying business is built on repeat use. Second‑quarter 2026 results showed net sales up 4.9% and organic sales up 2.4%, with gross margin expanding by 140 basis points and base business earnings per share rising 8%.
I like Colgate because it has a strong global presence and sells products people use every day. Its brands reach more than 200 countries, with recent growth led by emerging markets including India, Brazil, Mexico, and China. Things like toothpaste and soap are purchases consumers tend to keep making even when the economy slows, giving Colgate a dependable cash flow even when the market gets tough.
3. Walmart: value, automation, and a dividend baked into the plan
Walmart (NASDAQ: WMT) anchors budgets when the cost of money rises. In its 2026 reporting and annual materials, Walmart made it clear that its capital allocation approach starts with investing in growth, then prioritizes the dividend, and finally repurchases shares with remaining free cash flow. That framework has maintained a regular dividend while the company invests heavily in automation, data, and digital capabilities.
In the past, Walmart has said it will turn rising rates and inflation into reasons to get more efficient rather than pull back. Recently, this has looked more like leaning into automation. Last year, more than 60% of U.S. stores received part of their freight from automated distribution centers, and roughly half of e‑commerce volume flowed through automated facilities.
Those investments support the core promise of low prices and quick delivery, which helps keep traffic and membership strong even when borrowing costs climb.
How these three can work through more hikes
If the Fed continues to keep pushing rates higher, McDonald's, Colgate-Palmolive, and Walmart give you three different streams of cash backed by everyday behavior: eating out, brushing teeth, and cleaning. All three have raised or reaffirmed dividends in 2026 and are treating those payments as part of how they run the business, not a leftover, which is exactly the mindset you want on your side when the cost of money stays in motion longer than you do.
Should you buy stock in Colgate-Palmolive right now?
Before you buy stock in Colgate-Palmolive, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Colgate-Palmolive wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $384,839!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,385,657!*
Now, it’s worth noting Stock Advisor’s total average return is 936% — a market-crushing outperformance compared to 213% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of September 24, 2026.
Micah Zimmerman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Colgate-Palmolive and Walmart. The Motley Fool recommends the following options: long January 2028 $320 calls on McDonald's and short January 2028 $340 calls on McDonald's. The Motley Fool has a disclosure policy.

3 Dividend Stocks to Buy and Hold Even if the Fed Keeps Raising Interest Rates.

Key Points
Colgate-Palmolive was dropped from the S&P 100.
But its core business is still healthy, and it holds up well during recessions.
Colgate-Palmolive (NYSE: CL) has raised its dividend annually for 63 consecutive years. That makes it a Dividend King, or a company that has increased its payout for at least 50 years in a row, as well as a stable investment for income-oriented investors.
Over the past 20 years, it delivered a total return of 347% when reinvested dividends are included. It achieved that growth even as the U.S. endured two official recessions.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
But on Sept. 21, S&P Global removed Colgate-Palmolive from the S&P 100 index during its quarterly rebalancing, as its $69 billion market cap was too small to make the cut. That sounds like a major setback, but it doesn't change my bullish opinion about the stock.
Why isn't Colgate-Palmolive's exclusion from the S&P 100 meaningful?
Colgate-Palmolive remains in the S&P 500 (SNPINDEX: ^GSPC), so it will continue to be passively purchased by investors who buy index funds and ETFs tracking the S&P 500. Being removed from the S&P 100 will only eliminate Colgate-Palmolive's exposure to much smaller ETFs, such as iShares S&P 100 ETF (NYSEMKT: OEF), which track only the top 100 stocks.
Colgate-Palmolive wasn't dropped from the S&P 100 because its stock was sinking. Instead, it was removed because other higher-growth, AI-driven stocks -- including the newly added Palo Alto Networks, Sandisk, and Arista Networks -- grew faster and eclipsed its valuation. As a slower-growth consumer staples giant, Colgate-Palmolive simply couldn't keep up with those AI plays.
Why is Colgate-Palmolive still a solid long-term investment?
Colgate-Palmolive is still one of the largest producers of oral, personal, home care, and pet nutrition products in the world. Its best-known brands include Colgate, Palmolive, Protex, Speed Stick, Ajax, Fabuloso, Murphy, and Hill's premium pet food.
From 2025 to 2028, analysts expect Colgate-Palmolive's EPS to grow at a 17% CAGR from $2.63 to $4.22. That gives it plenty of room to raise its annual dividend, currently $2.12 per share, for a forward yield of 2.4%. That growth should be driven by its expansion of Hill's pet nutrition business, the premiumization of its personal care and household products, its robust sales in emerging markets, and new AI-driven optimization initiatives.
At $86, Colgate's stock still looks reasonably valued at 22 times next year's earnings. It's still a stable investment that usually holds up well during recessions, and it should gradually head higher over the next few years -- even if it never rejoins the highfliers of the S&P 100.
Should you buy stock in Colgate-Palmolive right now?
Before you buy stock in Colgate-Palmolive, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Colgate-Palmolive wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $389,154!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,406,303!*
Now, it’s worth noting Stock Advisor’s total average return is 949% — a market-crushing outperformance compared to 214% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of September 23, 2026.
Leo Sun has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Arista Networks, Colgate-Palmolive, and S&P Global. The Motley Fool recommends Palo Alto Networks. The Motley Fool has a disclosure policy.

This Dividend King Was Removed From the S&P 100. Here's Why It's a Great Buy for Long-Term Investors Anyway.

The Procter & Gamble Company PG and Colgate-Palmolive Company CL are two of the world’s most established consumer staples companies, but their competitive strengths are built on different foundations.
PG operates a broad portfolio spanning beauty, grooming, health care, fabric and home care, and family care, supported by globally recognized brands and leading positions across numerous categories. Colgate, meanwhile, is more concentrated, with a particularly powerful presence in oral care alongside personal care, home care and pet nutrition. This difference in business mix shapes how the two companies compete for market share. PG relies on its scale, category breadth, innovation and premium brands to defend leadership across multiple consumer markets, while Colgate draws strength from its dominant global toothpaste franchise and deep oral-care expertise.
As consumer preferences, pricing dynamics and competitive intensity evolve, comparing their market positions offers a revealing look at two distinct routes to sustained brand leadership.
The Case for PG
Procter & Gamble’s investment case rests on the scale and resilience of a portfolio that spans 10 major product categories and seven regions. In fiscal 2026, nine of 10 categories held or grew organic sales, while five of 10 held or gained global share. Twenty-six of its top 50 category-country combinations held or grew share, and aggregate global share exited the year flat after improving in the second half.
Its strategy centers on product superiority, premium brand positioning, innovation and disciplined reinvestment. PG is leaning into faster-growing Beauty and Health segments, while strengthening core franchises such as Tide, Charmin and Bounty. Its consumer base skews somewhat toward households earning above $100,000, although the portfolio spans price points and pack sizes for more value-conscious shoppers.
E-commerce grew 6% year over year and reached 20% of sales, while AI-enabled brand building, data platforms and digital retail partnerships are being scaled to sharpen engagement and conversion.
The company’s fiscal 2026 organic sales rose more than 1%, core EPS increased 1% to $6.89 and productivity savings reached $2.8 billion before tax. PG also returned more than $15 billion to shareholders, while continuing to fund innovation, advertising and digital capabilities.
The Case for CL
Colgate’s investment case is anchored in its global scale, category leadership and diversified exposure across Oral Care, Personal Care, Home Care and Hill’s Pet Nutrition. In the second quarter of 2026, organic sales grew in four of five divisions and three of four categories, while emerging markets advanced in the mid-single digits, led by India, Brazil, Mexico and China. Hill’s also outperformed its category, with organic sales, excluding private label, rising 4% against a roughly flat U.S. category.
Colgate is leaning on premiumization, science-led innovation and disciplined revenue growth management. In Oral Care, premium products such as Optic White, Elmex and Meridol are central to share expansion, while Hill’s targets pet owners seeking veterinarian-backed, science-based nutrition.
Emerging markets broaden the demographic opportunity, with Colgate balancing accessible price points for value-conscious consumers against premium offerings for higher-income shoppers. Europe’s toothpaste strategy shows this positioning clearly, with super-premium offerings driving growth while Colgate remains under-indexed in premium segments globally, leaving room for further expansion.
Digital capability is becoming another competitive lever. Colgate is scaling Promo AI, omni-demand generation and agentic tools, while 70% of vice presidents have received advanced AI training. Financially, the free cash flow rose 18%, $1.4 billion was returned to shareholders, the gross margin expanded 100 basis points and advertising increased double digits, supporting brand investment without sacrificing profitability.
How Do Estimates Compare for PG & CL?
The Zacks Consensus Estimate for Procter & Gamble’s fiscal 2027 sales and EPS implies year-over-year growth of 1.8% and 1.5%, respectively. EPS estimates for fiscal 2027 have moved down by a penny in the past 30 days.
The Zacks Consensus Estimate for Colgate’s 2026 sales and EPS suggests year-over-year growth of 4.8% and 4.9%, respectively. EPS estimates for 2026 have moved up by a penny in the past 30 days.
Consensus trends point to steadier but softer momentum for Procter & Gamble, with modest sales and earnings growth expectations and a slight downward EPS revision. Colgate shows comparatively stronger near-term momentum, supported by healthier projected sales and earnings growth and a recent upward EPS revision, signaling relatively firmer analyst confidence.
Price Performance & Valuation of Procter & Gamble, & Colgate
In the past year, PG shares have lost 4.2%, while the CL stock has risen 7.6%.
Procter & Gamble is trading at a forward 12-month price-to-earnings multiple of 20.62X, below its median of 23.33X in the last five years. Colgate’s forward 12-month P/E multiple sits at 21.43X, below its median of 23.49X in the last five years.
Share-price trends have diverged, with Procter & Gamble declining in the past year while Colgate has delivered positive returns. This suggests investors have recently shown greater confidence in Colgate’s growth trajectory and operating momentum, whereas PG’s slower growth profile and near-term cost pressures may have weighed on sentiment.
From a valuation standpoint, the figures provided indicate that both PG and Colgate are trading below their respective historical median forward P/E multiples. This suggests that current valuations are less demanding than their longer-term norms, potentially reflecting cautious expectations around consumer demand, inflation and earnings growth.
Conclusion
Taken together, the face-off favors Colgate. While Procter & Gamble offers unmatched scale, portfolio breadth and brand strength, Colgate currently shows stronger operating momentum, supported by premiumization, oral-care leadership, emerging-market growth and expanding digital capabilities. Its superior one-year share performance also reflects comparatively stronger market confidence.
Colgate’s earnings outlook further strengthens its case. Consensus estimates point to healthier sales and profit growth, while the recent upward earnings revision signals improving confidence in its earnings potential. PG’s growth outlook appears more subdued alongside a slight downward estimate revision. Overall, Colgate emerges as the stronger pick in this comparison.
Both Procter & Gamble and Colgate currently carry a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.
Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.
Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.
See Top Quantum Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

PG vs. CL: Which Consumer Staples Giant Has Stronger Market Position?

The Procter & Gamble Company PG enters fiscal 2027 with a greater focus on balancing pricing with volume growth as it navigates a challenging consumer environment and elevated costs. In fiscal 2026, organic sales increased 1%, with pricing contributing one point, while volume was up modestly for the fiscal year. However, momentum remained limited in the fourth quarter, when volume rounded down to flat and pricing and mix were neutral.
Pricing can provide a near-term lift to sales, particularly when backed by strong brands, product innovation and perceived value. However, sustained volume growth remains important for PG, as higher unit sales can provide a broader and more durable foundation for revenue growth. At the same time, continued price increases may put pressure on consumer affordability, potentially prompting shoppers to trade down, opt for private-label products or reduce purchase frequency.
Nevertheless, PG does not intend to rely solely on pricing to support growth. Management expects promotions to move toward pre-pandemic levels while continuing to drive price/mix. The company has been emphasizing innovation designed to support pricing while delivering stronger value to consumers. Management expects this approach to result in a more balanced contribution from volume, price and mix in fiscal 2027.
That said, PG’s diverse portfolio of leading brands, continued innovation, productivity initiatives and premium offerings should support growth. The company is also focused on enhancing consumer value through effective price-pack architecture while strengthening brand equity. Going forward, PG’s fiscal 2027 growth strategy is likely to emphasize innovation, volume recovery, disciplined pricing and productivity gains, reducing its reliance on pricing as the primary growth driver.
PG’s Competition
Colgate-Palmolive Company CL is enhancing its operations to become more connected, efficient and resilient by leveraging digital technologies, data analytics, automation and stronger supplier collaboration. CL’s productivity initiatives are increasingly playing a critical role in supporting margins as it navigates persistent cost inflation and uneven category demand. With a diversified portfolio of everyday consumer essentials spanning multiple price points and a strong presence in faster-growing emerging markets, Colgate is well-positioned to drive sustainable growth and strengthen its competitive position.
The Clorox Company CLX is implementing a streamlined operating model designed to simplify processes, lower costs and create a faster, more focused organization. CLX is optimizing its portfolio, increasing investments in innovation and brand building, and expanding its presence in the health and hygiene categories. These initiatives, supported by greater sourcing flexibility and adaptable business models, are helping Clorox manage cost inflation while advancing its strategic priorities and strengthening operational efficiency.
PG’s Price Performance, Valuation and Estimates
Procter & Gamble’s shares have gained 3% in the past six months compared with the industry’s 2% growth.
From a valuation standpoint, PG is trading at a forward price-to-earnings ratio of 20.67X compared with the industry’s average of 18.25X.
The Zacks Consensus Estimate for PG’s fiscal 2027 and fiscal 2028 earnings per share (EPS) indicates year-over-year growth of 1.5% and 6.2%, respectively. The company’s EPS estimate for fiscal 2027 has moved south while that of fiscal 2028 has been stable in the past 30 days.
Procter & Gamble currently carries a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Will Pricing Sustain Procter & Gamble as Volume Growth Stays Elusive?

General Mills, Inc. GIS is likely to witness a top-and bottom-line decline when it reports first-quarter fiscal 2027 earnings on Sept. 8. The Zacks Consensus Estimate for revenues is pegged at $4.3 billion, indicating a decrease of 3.8% from the year-ago reported number.
The consensus mark for earnings has remained unchanged over the past 30 days at 72 cents a share, which suggests a decline of 16.3% from the figure recorded in the year-ago period. GIS has a trailing four-quarter surprise of 4.1%, on average.
Factors Likely to Influence GIS’ Upcoming Results
General Mills’ fiscal first-quarter performance is likely to have benefited from its sharper focus on product innovation and renovation following the completion of its base-price investment actions. Management has prioritized offerings tied to consumer demand spaces such as protein, fiber, bold flavors, indulgence and pet humanization. These initiatives, along with refreshed packaging and brand communications, are likely to have helped improve brand relevance and supported consumer engagement.
Within North America Retail, innovation across key brands such as Cheerios, Nature Valley, Annie’s and Old El Paso is likely to have supported performance. The company is also expanding distribution for La Tiara and Ghost while launching Wanchai Ferry frozen dumplings in club stores during the summer. On its lastearnings call management noted that these premium offerings are intended to support positive price/mix as the business enters new growth spaces.
North America Pet is likely to have benefited from continued momentum in Tastefuls and Tiki Cat, supported by higher brand investment, innovation and broader distribution. Efforts to strengthen Blue Buffalo’s Life Protection Formula and improve Love Made Fresh availability are also likely to have helped. On the margin front, HMM productivity, Strategic Revenue Management, premium innovation and price-pack architecture may have provided some support, although cost savings were expected to build gradually through the year.
However, a still-pressured consumer environment and subdued category growth are likely to have weighed on volumes. Management specifically indicated that first-quarter results are expected to fall below full-year guidance ranges, reflecting shipment-timing headwinds in North America Retail and North America Pet, as well as the timing of cost-savings realization.
In Pet, customer inventory management and an unfavorable customer mix are also expected to cause organic sales growth to lag retail sales growth in the quarter. Our model suggests organic sales declines of 4% and 4.8% for the North America Retail and North America Pet segments, respectively, in the first quarter.
Earnings Whispers for GIS
Our proven model predicts an earnings beat for General Mills this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is exactly the case here.
General Mills currently carries a Zacks Rank #3 and has an Earnings ESP of +1.47%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Other Stocks With the Favorable Combination
Here are some other companies worth considering, as our model shows that these, too, have the right combination of elements to beat on earnings this reporting cycle.
Colgate-Palmolive Company CL currently has an Earnings ESP of +1.94% and a Zacks Rank of 3. The Zacks Consensus Estimate for its upcoming quarter’s revenues is pegged at $5.3 billion, indicating an approximately 4% rise from the figure reported in the prior-year quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for Colgate-Palmolive’s earnings is pegged at 92 cents per share, implying 1.1% growth from the year-ago quarter. CL delivered a trailing four-quarter earnings surprise of 3.2%, on average.
Philip Morris International Inc. PM currently has an Earnings ESP of +3.41% and a Zacks Rank of 3. The consensus estimate for the quarterly revenues is pinned at $11.3 billion, which suggests 4.3% growth from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for Philip Morris’ upcoming quarter’s EPS is pegged at $2.26, which calls for a 0.9% increase from the year-ago period figure. PM delivered a trailing four-quarter earnings surprise of 6%, on average.
The Coca-Cola Company KO currently has an Earnings ESP of +0.57% and a Zacks Rank #3. The consensus estimate for quarterly revenues is pegged at $12.9 billion, which indicates an improvement of about 4% from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for Coca-Cola’s upcoming quarter’s EPS is pegged at 87 cents, which calls for 6.1% growth from the figure reported in the prior-year quarter. KO delivered a trailing four-quarter earnings surprise of 4.6%, on average.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).

Indicator	Dec 25	Mar 26	Jun 26	TTM
Net Income	RUB 0.00	RUB 646.00M	RUB 693.00M	RUB 693.00M
Operating Income	RUB 91.00M	RUB 964.00M	RUB 1.02B	RUB 1.02B

Indicator	Dec 25	Mar 26	Jun 26	TTM
Total Assets	RUB 16.33B	RUB 16.61B	RUB 16.79B	RUB 16.79B
Cash on Hand	RUB 1.29B	RUB 1.34B	RUB 1.37B	RUB 1.37B
Total share holder equity	RUB 365.00M	RUB 486.00M	RUB 566.00M	RUB 566.00M

Indicator	Dec 25	Mar 26	Jun 26	TTM
Long Term Debt	RUB 6.87B	RUB 7.94B	RUB 7.82B	RUB 7.82B
Total liabilities	RUB 15.97B	RUB 16.12B	RUB 16.22B	RUB 16.22B

Colgate-Palmolive Company

Recent quarterly and TTM performance

Growth

Assets

Debts